In a report released yesterday, Steve Baxter from Wells Fargo maintained a Buy rating on UnitedHealth (UNH – Research Report), with a price target of $525.00. The company’s shares closed last Friday at $439.20.
According to TipRanks, Baxter is an analyst with an average return of -1.0% and a 41.01% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Humana, Elevance Health, and Molina Healthcare.
In addition to Wells Fargo, UnitedHealth also received a Buy from Piper Sandler’s Jessica Tassan in a report issued on April 11. However, on April 12, Jefferies maintained a Hold rating on UnitedHealth (NYSE: UNH).
UNH market cap is currently $404.9B and has a P/E ratio of 18.41.
Based on the recent corporate insider activity of 146 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UNH in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
UnitedHealth (UNH) Company Description:
UnitedHealth Group, Inc. is a diversified healthcare company, offering healthcare coverage and benefits services through UnitedHealthcare, and information and technology-enabled health services through Optum. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.
Read More on UNH:
- UNH Upcoming Earnings Report: What to Expect?
- Insiders Sold UnitedHealth (NYSE:UNH) Shares Before DoJ Probe Became Public
- UnitedHealth price target lowered to $546 from $607 at TD Cowen
- UnitedHealth price target lowered to $534 from $551 at Barclays
- UnitedHealth price target lowered to $584 from $618 at Morgan Stanley
